Fig. 3From: The ideal approach for treatment of cT1N+ and cT2Nany esophageal cancer.: a NCDB analysisNeoadjuvant chemotherapy and neoadjuvant chemoradiotherapy cohorts were associated with a better trend for OS compared to neoadjuvant radiotherapy alone, but the difference was not significant (P=0.377, P= 0.311, respectively). There was no difference in OS between neoadjuvant chemoradiotherapy vs neoadjuvant chemotherapy alone (P=0.926)Back to article page